| Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group S Kelly, N Jahanshad, A Zalesky, P Kochunov, I Agartz, C Alloza, ... Molecular psychiatry 23 (5), 1261-1269, 2018 | 631 | 2018 |
| Studies on [3H] CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use B Dean, S Sundram, R Bradbury, E Scarr, D Copolov Neuroscience 103 (1), 9-15, 2001 | 523 | 2001 |
| Accelerated gray and white matter deterioration with age in schizophrenia VL Cropley, P Klauser, RK Lenroot, J Bruggemann, S Sundram, ... American Journal of Psychiatry 174 (3), 286-295, 2017 | 186 | 2017 |
| Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia E Scarr, TF Cowie, S Kanellakis, S Sundram, C Pantelis, B Dean Molecular psychiatry 14 (11), 1017-1023, 2009 | 162 | 2009 |
| Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder E Scarr, G Pavey, S Sundram, A MacKinnon, B Dean Bipolar Disorders 5 (4), 257-264, 2003 | 147 | 2003 |
| Mental disorders in asylum seekers: The role of the refugee determination process and employment DC Hocking, GA Kennedy, S Sundram The Journal of nervous and mental disease 203 (1), 28-32, 2015 | 126 | 2015 |
| Altered hippocampal muscarinic M4, but not M1, receptor expression from subjects with schizophrenia E Scarr, S Sundram, D Keriakous, B Dean Biological psychiatry 61 (10), 1161-1170, 2007 | 122 | 2007 |
| Cannabis and neurodevelopment: implications for psychiatric disorders S Sundram Human Psychopharmacology: Clinical and Experimental 21 (4), 245-254, 2006 | 122 | 2006 |
| Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects AS Gibbons, E Scarr, C McLean, S Sundram, B Dean Journal of affective disorders 116 (3), 184-191, 2009 | 110 | 2009 |
| A brief dyadic group based psychoeducation program improves relapse rates in recently remitted bipolar disorder: a pilot randomised controlled trial R D'Souza, D Piskulic, S Sundram Journal of Affective Disorders 120 (1-3), 272-276, 2010 | 104 | 2010 |
| Neuregulin-1 and schizophrenia in the genome-wide association study era MS Mostaid, D Lloyd, B Liberg, S Sundram, A Pereira, C Pantelis, T Karl, ... Neuroscience & Biobehavioral Reviews 68, 387-409, 2016 | 89 | 2016 |
| Mirtazapine add‐on therapy in the treatment of schizophrenia with atypical antipsychotics: a double‐blind, randomised, placebo‐controlled clinical trial M Berk, CS Gama, S Sundram, H Hustig, L Koopowitz, R D'Souza, ... Human Psychopharmacology: Clinical and Experimental 24 (3), 233-238, 2009 | 87 | 2009 |
| The impact of premorbid and current intellect in schizophrenia: cognitive, symptom, and functional outcomes R Wells, V Swaminathan, S Sundram, D Weinberg, J Bruggemann, ... npj Schizophrenia 1 (1), 1-8, 2015 | 77 | 2015 |
| Are patients with schizophrenia impaired in processing non-emotional features of human faces? H Darke, JS Peterman, S Park, S Sundram, O Carter Frontiers in psychology 4, 529, 2013 | 67 | 2013 |
| Widespread volumetric reductions in schizophrenia and schizoaffective patients displaying compromised cognitive abilities TE Van Rheenen, V Cropley, A Zalesky, C Bousman, R Wells, ... Schizophrenia bulletin 44 (3), 560-574, 2018 | 65 | 2018 |
| Clozapine decreases [3H] CP 55940 binding to the cannabinoid1 receptor in the rat nucleus accumbens S Sundram, D Copolov, B Dean Naunyn-Schmiedeberg's archives of pharmacology 371, 428-433, 2005 | 58 | 2005 |
| Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions HF North, J Bruggemann, V Cropley, V Swaminathan, S Sundram, ... European archives of psychiatry and clinical neuroscience 271, 595-607, 2021 | 51 | 2021 |
| The impact of childhood adversity on cognitive development in schizophrenia R Wells, I Jacomb, V Swaminathan, S Sundram, D Weinberg, ... Schizophrenia Bulletin 46 (1), 140-153, 2020 | 49 | 2020 |
| Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorder B Dean, A Digney, S Sundram, E Thomas, E Scarr Psychiatry research 158 (1), 75-78, 2008 | 47 | 2008 |
| Meta-analysis reveals associations between genetic variation in the 5′ and 3′ regions of Neuregulin-1 and schizophrenia MS Mostaid, SG Mancuso, C Liu, S Sundram, C Pantelis, IP Everall, ... Translational psychiatry 7 (1), e1004-e1004, 2017 | 44 | 2017 |
Christos PantelisProfessor of Neuropsychiatry, University of Melbourne在 unimelb.edu.au 的电子邮件经过验证
